• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

RelayHealth, McKesson Rx Automation, RxCrossroads Unifies Under CoverMyMeds Brand

by Fred Pennic 05/26/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
RelayHealth, McKesson Prescription Automation, CoverMyMeds, and RxCrossroads by McKesson have unified as one business and one team under the CoverMyMeds brand

What You Should Know:

– Today, CoverMyMeds announced that RelayHealth, McKesson Prescription Automation, CoverMyMeds, and RxCrossroads by McKesson have unified as one business and one team under the CoverMyMeds brand.

– Together, the technology innovation and robust connections to providers, pharmacies, payers, and biopharma provided by RelayHealth and CoverMyMeds; RxCrossroads’ deep therapeutic and drug commercialization expertise; and McKesson Prescription Automation’s trusted pharmacy automation technology and services will help improve care in every setting and solve some of the biggest medication access, adherence and affordability challenges patients face.

– To date, the teams collectively assisted over 50 million patients in accessing their prescribed therapies and also helped patients save billions of dollars in out-of-pocket prescription costs.

“Coming together as CoverMyMeds aligns our capabilities around the patient journey and creates a cohesive experience for our customers, patients and employees. Our unification also reflects McKesson’s continued commitment and investment in our brand, our customers and our employees, which ultimately positions us for long-term growth. In fact, Brian Tyler, the CEO of McKesson, recently shared that under a single cohesive go-to-market strategy, our business is positioned to accelerate its growth this year, as patient mobility improves and prescription trends recover,” said Nathan Mott, President of CoverMyMeds.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: CoverMyMeds, mckesson, relayhealth

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |